# First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EGFR</i>Mutations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-gefitinib-in-patients-with-advanced-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lecia V. Sequist,Renato Martins,David R. Spigel,Steven M. Grunberg,Alexander I. Spira,Pasi A. Jänne,Victoria A. Joshi,David McCollum,Tracey L. Evans,Alona Muzikansky,Georgiana Kuhlmann,Moon Hi Han,Jonathan S. Goldberg,Jeffrey Settleman,A. John Iafrate,Jeffrey A. Engelman,Daniel A. Haber,Bruce E. Johnson,Thomas J. Lynch |
| Citations | 835 |
| DOI | 10.1200/jco.2007.14.8494 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.14.8494?role=tab |
| OpenAlex ID | https://openalex.org/W2101329867 |
| PMID | 18458038 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Lecia V. Sequist](https://scholariq.org/researchers/lecia-v-sequist/)
- [Pasi A. Jänne](https://scholariq.org/researchers/pasi-a-janne/)
- [A. John Iafrate](https://scholariq.org/researchers/a-john-iafrate/)
- [Alona Muzikansky](https://scholariq.org/researchers/alona-muzikansky/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)
- [Jeffrey A. Engelman](https://scholariq.org/researchers/jeffrey-a-engelman/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.